An Initial Double-Blind, Placebo-Controlled Two-Dose Crossover Study of AZD7325 in Adults With Fragile X Syndrome
Phase of Trial: Phase I
Latest Information Update: 09 Mar 2018
At a glance
- Drugs AZD 7325 (Primary)
- Indications Fragile X syndrome
- Focus Therapeutic Use
- 05 Mar 2018 Status changed from not yet recruiting to recruiting.
- 18 Jul 2017 Planned initiation date changed from 1 May 2017 to 1 Aug 2017.
- 08 May 2017 New trial record